From readiness to real-world rollout: Vita Embryo is now being adopted across clinics

After completing key readiness milestones last year, Kai Health is now in an active rollout phase. Multiple clinics are moving from discussions to contracts, onboarding, and routine use, keeping our commercial team busy with weekly site visits and launch support.

Vita Embryo is a software solution that analyzes Day 5 embryo images and provides additional quantitative insights to support clinical decision-making at the point of embryo ranking. It can be applied regardless of the number of embryos available, whether a clinic is selecting among several embryos or making a decision with only one.

What we’re hearing from the field:

Early feedback in Korea is consistent: clinics are not looking for AI to make decisions in place of clinicians. Instead, they value AI for improving consistency and standardization, helping teams align faster and communicate decisions more clearly.

What’s next (roadmap direction):

We are also preparing improvements frequently requested by clinics, such as broader analysis coverage (e.g., earlier-stage analysis), more explainable outputs, and expanded compatibility with additional imaging workflows.

If your clinic is interested in a demo or onboarding consultation, please reach out to our commercial team.